
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 19, 2023, titled "Zydus receives EIR for the formulation manufacturing facility at SEZ 2, Ahmedabad".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 19, 2023, titled "Zydus receives EIR for the formulation manufacturing facility at SEZ 2, Ahmedabad".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences